5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The Sweden Neurology Devices Market is segmented by Type of Device (Cerebrospinal Fluid Management Device, Interventional Neurology Device, Neurosurgery Device, Neurostimulation Device, and Other Type of Devices).
The Sweden Neurology Devices Market is expected to grow with a CAGR of 4.5% during the forecasted period. The key factors propelling the growth of this market are increase in incidence of neurological disorders,huge investments by private players in neurology devices and increase in R&D in the field of neurotherapies.
According to the World Population Ageing 2019 report, in South Africa population aged 65 years or over in 2019 was 2.027 million (20.2%) and this number is projected to reach to 2.355 million (22.2%) in 2030. As number of geriatric population is expected to increase in coming years who are more prone to disorders such as cognitive impairment and dementia which ultimately rises the growth of market in near future.
Thus, owing to above factors the market is expected to show significant growth over the forecast period.
As per the scope of the report, neurological devices are medical devices that help to diagnose, prevent, and treat a variety of neurological disorders and conditions, such as Alzheimer's disease, Parkinson’s disease, major depression, and traumatic brain injury. The Sweden Neurology Devices Market is segmented by type of device (Cerebrospinal Fluid Management Device, Interventional Neurology Device, Neurosurgery Device, Neurostimulation Device, and Other Type of Devices).
Report scope can be customized per your requirements. Click here.
The sacral nerve stimulation devices are mostly used for patients for whom drug therapy or other types of medications are not successful. It is performed with the help of a small device, which is capable of sending electrical impulses to the targeted sacral nerves located in the lower back region. These devices are found to be successful in treating bladder problems. Hence, with increasing incidences of overactive bladder, the sacral nerve stimulation devices segment is expected to grow during the forecast period.
Sacral nerve stimulation devices are an effective and safe treatment for patients suffering from fecal and urinary dysfunction. Increasing demand for the minimal invasive therapy, rising prevalence of urinary bladder diseases, and technological advancements such as introduction of novel coatings and engineering strategies are the main factors driving the growth of the market.
In sweden, Medtronic Plc offers "The InterStim II" is an implantable neurostimulator that gently stimulates the sacral nerve, which is thought to normalize neural communication between the bladder and brain and between the bowel and brain. It is used in overactive bladder (OAB), non-obstructive urinary retention, and chronic fecal incontinence conditions.
Thus, owing to above factors the segment is expected to show significant growth over the forecast period.
To understand key trends, Download Sample Report
The Sweden Neurology Devices Market is fragmented competitive. There are market participants involved in R&D for the development of advanced stimulation and neuromodulation techniques with minimally invasive procedures that are more preferable to the patients. Furthermore, many private companies are showing great interest in developing novel neurological devices to earn huge profits. In the coming years few other players are expected to enter into the market.
1.1 Study Assumptions
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Incidence of Neurological Disorders
4.2.2 Huge Investments by Private Players in Neurology Devices
4.2.3 Increase in R&D in the Field of Neurotherapies
4.3 Market Restraints
4.3.1 High Cost of Equipment
4.3.2 Stringent FDA Validation and Guidelines for New Devices
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Type of Device
5.1.1 Cerebrospinal Fluid Management Devices
5.1.2 Interventional Neurology Devices
220.127.116.11 Interventional/Surgical Simulators
18.104.22.168 Neurothrombectomy Devices
22.214.171.124 Carotid Artery Stents
126.96.36.199 Embolic Coils
188.8.131.52 Support Devices
5.1.3 Neurosurgery Devices
184.108.40.206 Stereotactic Systems
220.127.116.11 Aneurysm Clips
18.104.22.168 Other Neurosurgery Devices
5.1.4 Neurostimulation Devices
22.214.171.124 Spinal Cord Stimulation Devices
126.96.36.199 Deep Brain Stimulation Devices
188.8.131.52 Sacral Nerve Stimulation Devices
184.108.40.206 Other Neurostimulation Devices
220.127.116.11 Other Types of Devices
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 B. Braun Melsungen AG
6.1.2 Stryker Corporation
6.1.3 Boston Scientific Corporation
6.1.4 Medtronic PLC
6.1.5 Abbott Laboratories
6.1.6 Nihon Kohden Corporation
6.1.7 Smith & Nephew
6.1.8 Integra LifeSciences Corporation
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments